Journal
DIABETES CARE
Volume 43, Issue 8, Pages 1695-1703Publisher
AMER DIABETES ASSOC
DOI: 10.2337/dc20-1192
Keywords
-
Categories
Funding
- Wellcome Trust
- National Institutes of Health [UL1TR002489, P30DK124723]
- National Institute for Health Research (NIHR) Applied Research Collaboration East Midland (NIHR ARC-EM)
- NIHR Leicester Biomedical Research Centre
Ask authors/readers for more resources
Evidence relating to the impact of COVID-19 in people with diabetes (PWD) is limited but continuing to emerge. PWD appear to be at increased risk of more severe COVID-19 infection, though evidence quantifying the risk is highly uncertain. The extent to which clinical and demographic factors moderate this relationship is unclear, though signals are emerging that link higher BMI and higher HbA(1c)to worse outcomes in PWD with COVID-19. As well as posing direct immediate risks to PWD, COVID-19 also risks contributing to worse diabetes outcomes due to disruptions caused by the pandemic, including stress and changes to routine care, diet, and physical activity. Countries have used various strategies to support PWD during this pandemic. There is a high potential for COVID-19 to exacerbate existing health disparities, and research and practice guidelines need to take this into account. Evidence on the management of long-term conditions during national emergencies suggests various ways to mitigate the risks presented by these events.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available